Patent Number 8680182
The present invention provides methods of promoting the revascularization and/or reenervation of central nervous system lesions using an in-situ crosslinkable hydrogel. The present invention also provides methods of treating a spinal cord injury by topically delivering to the spinal cord injury site a vehicle comprising a neurotrophic factor and/or anti-inflammatory agent. Also provided are methods of treating a spinal cord injury by topically administering or delivering a hydrogel to the injury site.
Clemson University Research Foundation (Clemson, SC)
424/1.45; 424/409; 424/422; 424/423; 424/425; 424/444; 424/456; 424/499; 424/78.05; 424/78.08; 524/916